JPS55106264A - Manufacture of benzimidazolylbenzofurans - Google Patents

Manufacture of benzimidazolylbenzofurans

Info

Publication number
JPS55106264A
JPS55106264A JP1257680A JP1257680A JPS55106264A JP S55106264 A JPS55106264 A JP S55106264A JP 1257680 A JP1257680 A JP 1257680A JP 1257680 A JP1257680 A JP 1257680A JP S55106264 A JPS55106264 A JP S55106264A
Authority
JP
Japan
Prior art keywords
benzimidazolylbenzofurans
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP1257680A
Other languages
English (en)
Inventor
Beerinku Berunharuto
Buremen Yozefu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AG filed Critical Bayer AG
Publication of JPS55106264A publication Critical patent/JPS55106264A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
JP1257680A 1979-02-08 1980-02-06 Manufacture of benzimidazolylbenzofurans Pending JPS55106264A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792904829 DE2904829A1 (de) 1979-02-08 1979-02-08 Verfahren zur herstellung von benzimidazolylbenzofuran

Publications (1)

Publication Number Publication Date
JPS55106264A true JPS55106264A (en) 1980-08-14

Family

ID=6062480

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1257680A Pending JPS55106264A (en) 1979-02-08 1980-02-06 Manufacture of benzimidazolylbenzofurans

Country Status (5)

Country Link
US (1) US4268670A (ja)
EP (1) EP0014411B1 (ja)
JP (1) JPS55106264A (ja)
BR (1) BR8000748A (ja)
DE (2) DE2904829A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364944A (en) * 1989-10-27 1994-11-15 American Home Products Corporation Substituted benzoylbenzene-, biphenyl- and 2-oxazole- alkanoic acid compounds
US6048927A (en) * 1999-03-01 2000-04-11 Dow Corning Corporation Method for forming fiber treating composition comprising an amide-functional polyorganosiloxane and an alkylsulfate of benzimidazole
DE20002868U1 (de) 2000-02-17 2000-05-04 Frenger Systemen Bv Heiz Und K Strahlflächenaufbau
US6448281B1 (en) 2000-07-06 2002-09-10 Boehringer Ingelheim (Canada) Ltd. Viral polymerase inhibitors
EP2335700A1 (en) 2001-07-25 2011-06-22 Boehringer Ingelheim (Canada) Ltd. Hepatitis C virus polymerase inhibitors with a heterobicylic structure
US7098231B2 (en) 2003-01-22 2006-08-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7223785B2 (en) 2003-01-22 2007-05-29 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
US7582770B2 (en) 2004-02-20 2009-09-01 Boehringer Ingelheim International Gmbh Viral polymerase inhibitors
EP1915378A4 (en) 2005-08-12 2009-07-22 Boehringer Ingelheim Int VIRUS POLYMERASE INHIBITORS
ES2790358T3 (es) 2011-12-28 2020-10-27 Global Blood Therapeutics Inc Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular
PT2797416T (pt) 2011-12-28 2017-10-23 Global Blood Therapeutics Inc Compostos de benzaldeído substituído e métodos para a sua utilização no aumento da oxigenação de tecidos
US10100043B2 (en) 2013-03-15 2018-10-16 Global Blood Therapeutics, Inc. Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation
US8952171B2 (en) 2013-03-15 2015-02-10 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9802900B2 (en) 2013-03-15 2017-10-31 Global Blood Therapeutics, Inc. Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin
US10266551B2 (en) 2013-03-15 2019-04-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9604999B2 (en) 2013-03-15 2017-03-28 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US9422279B2 (en) 2013-03-15 2016-08-23 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
AP2015008718A0 (en) 2013-03-15 2015-09-30 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
CN105073728A (zh) 2013-03-15 2015-11-18 全球血液疗法股份有限公司 化合物及其用于调节血红蛋白的用途
US9458139B2 (en) 2013-03-15 2016-10-04 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
US20140274961A1 (en) 2013-03-15 2014-09-18 Global Blood Therapeutics, Inc. Compounds and uses thereof for the modulation of hemoglobin
MY180206A (en) 2013-03-15 2020-11-25 Global Blood Therapeutics Inc Compounds and uses thereof for the modulation of hemoglobin
EA201992707A1 (ru) 2013-11-18 2020-06-30 Глобал Блад Терапьютикс, Инк. Соединения и их применения для модуляции гемоглобина
DK3102208T3 (da) 2014-02-07 2021-03-08 Global Blood Therapeutics Inc Krystallinsk polymorf af den frie base af 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyd
MA41841A (fr) 2015-03-30 2018-02-06 Global Blood Therapeutics Inc Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs
MA43373A (fr) 2015-12-04 2018-10-10 Global Blood Therapeutics Inc Régimes posologiques pour 2-hydroxy-6-((2- (1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)méthoxy)benzaldéhyde
AR108435A1 (es) 2016-05-12 2018-08-22 Global Blood Therapeutics Inc Proceso para sintetizar 2-hidroxi-6-((2-(1-isopropil-1h-pirazol-5-il)-piridin-3-il)metoxi)benzaldehído
TWI778983B (zh) 2016-10-12 2022-10-01 美商全球血液治療公司 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑
WO2020072377A1 (en) 2018-10-01 2020-04-09 Global Blood Therapeutics, Inc. Modulators of hemoglobin for the treatment of sickle cell disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3940417A (en) * 1970-12-09 1976-02-24 Ciba-Geigy Corporation Quaternised benzofuranyl-benzimidazoles
BE787580A (fr) * 1971-08-13 1973-02-14 Hoechst Ag Procede de preparation de derives du furanne
DE2304265A1 (de) * 1973-01-30 1974-08-01 Basf Ag 6-triazolyl-(2')-benzofurane und optische aufheller
CH632628B (de) * 1976-07-26 Ciba Geigy Ag Verfahren zur herstellung von benzofuranyl-benzimidazolen und deren verwendung als optische aufheller.
US4143055A (en) * 1978-03-27 1979-03-06 Gruppo Lepetit S.P.A. 2,4,6-trisubstituted-2,3-dihydro-benzofuran derivatives
EP0010063B1 (de) * 1978-10-04 1982-12-29 Ciba-Geigy Ag Verfahren zur Herstellung von Furanyl-benzazolen

Also Published As

Publication number Publication date
EP0014411B1 (de) 1981-10-07
DE2904829A1 (de) 1980-08-14
BR8000748A (pt) 1980-10-21
EP0014411A1 (de) 1980-08-20
US4268670A (en) 1981-05-19
DE3060027D1 (en) 1981-12-17

Similar Documents

Publication Publication Date Title
JPS5616486A (en) Manufacture of oxoalkylxanthine
JPS55106264A (en) Manufacture of benzimidazolylbenzofurans
JPS5612360A (en) Manufacture of oosubstituteddketoxime
JPS5640649A (en) Manufacture of diesterdiamide
JPS55154968A (en) Manufacture of epsilonncaprolactone
JPS55137115A (en) Manufacture of carboxyllatex
JPS5625153A (en) Manufacture of methylenecycloamines
JPS55105632A (en) Manufacture of etheralcohol
JPS55130966A (en) Manufacture of thiazolidinee22thione
JPS55133361A (en) Manufacture of hydroxyethylazoles
JPS5636439A (en) Manufacture of betaaaminopropionamide
JPS55125156A (en) Manufacture of 11aminoo22phenoxyy44hydroxyyanthraquinone
JPS5616419A (en) Manufacture of trifluoromethylnaphthalene
JPS55111464A (en) Manufacture of 77acylindolinee22one
JPS5626828A (en) Manufacture of 44fluoroo33phenoxyytoluene
JPS5618990A (en) Manufacture of trialkoxysilanols
JPS55160770A (en) Manufacture of hexafluorotriarylisocyanurate
JPS5640663A (en) Manufacture of pyrrolee22acetate
JPS5626880A (en) Manufacture of 22isopropylaminoopyrimidine
JPS56123967A (en) Manufacture of omegaalactam
JPS5632449A (en) Manufacture of naphthalenesulfonylchloride
JPS5620561A (en) Manufacture of benzylcyanides
JPS5629559A (en) Manufacture of alphaahydroxyoxime
JPS5610177A (en) Manufacture of 22isopropylaminopyrimidine
JPS5612388A (en) Manufacture of pyrenzepin